In a setback for generics makers, AstraZeneca prevailed in a patent-infringement lawsuit when a federal judge validated the company’s patent for the diabetes drug Onglyza.
Source: Drug Industry Daily
In a setback for generics makers, AstraZeneca prevailed in a patent-infringement lawsuit when a federal judge validated the company’s patent for the diabetes drug Onglyza.
Source: Drug Industry Daily